1. Introduction {#sec1}
===============

Chronic hepatitis B virus (CHB) infection is a leading cause of cirrhosis and hepatocellular carcinoma (HCC) and, in addition to morbidity and mortality, creates significant economic and social burdens \[[@B1], [@B2]\]. It is estimated that approximately 240 million people have CHB infection worldwide and CHB infection should be responsible for 650,000 cases of hepatocellular carcinoma \[[@B2], [@B3]\]. Due to the pathogenicity of CHB, early detection of CHB infection is the goal of treatment to diagnose and prevent the progression \[[@B4]\]. To this end, several hepatitis B virus (HBV) markers have been identified, including antigens (hepatitis B surface antigen, HBsAg; hepatitis Be antigen, HBeAg; hepatitis B core antigen, HBcAg), antibodies (hepatitis surface antibody, anti-HBs; hepatitis Be antibody, anti-HBe; hepatitis B core antibody, anti-HBc), and immunoglobulin (Ig) G and immunoglobulin M; however, unequivocal diagnosis requires more biomarkers \[[@B5]\].

By traditional Chinese medicine (TCM) pattern classification, CHB infected patients are accordingly classified into six subtypes \[[@B6]\]: (1) damp heat stasis in the middle-jiao (DHSM), (2) liver Qi stagnation and spleen deficiency (LSSD), (3) Yang deficiency of spleen and kidney (YDSK), (4) Yin deficiency of liver and kidney (YDLK), (5) blood stasis into collateral (BSIC), and (6) damp heat complicated with blood stasis (DHBS). Among them DHSM and LSSD are two most common CHB subtypes and have unique syndromes in clinic. For example, LSSD patients always have main syndromes, such as (Mi) flank pain and (Mii) abdominal distension and loose stools, and secondary symptoms, including (Si) depression and boredom, (Sii) body tired fatigue, and (Siii) pale tongue with teeth marks. DHSM patients have another two main syndromes, such as (M1) abdominal distension and (M2) yellow greasy moss, and three secondary syndromes, including (S1) nausea, being tired of the oil, and poor appetite, (S2) jaundice, bright color, and dark urine, and (S3) viscous stool foul smell. However, these syndromes are diagnosed by TCM doctors according to their experiences and the molecular biomarkers remain unclear.

Proteomics is a powerful technology recently developed to enhance our study on the diagnosis, treatment, and prevention of human diseases \[[@B7]\]. Among the proteomics technologies iTRAQ (isobaric Tags for Relative and Absolute Quantitation) has become popular for protein identification and quantification due to its sensitivity, accuracy, and high throughput \[[@B8]\]. It has been used to identify biomarker proteins for different stages of hepatitis B related diseases in patients and cellular models \[[@B9]--[@B12]\]. Several serum proteins have been reported to be potential biomarkers for CHB, such as actin \[[@B13]\], apolipoproteins A-I and A-IV \[[@B14]\], complement component \[[@B15]\], immunoglobulin related proteins \[[@B15], [@B16]\], haptoglobins *β* and *α*2 chain \[[@B14]\], and transferrin \[[@B17]\].

In this study, we employed iTRAQ combined with LC-ESI-MS/MS analyses to investigate protein biomarkers in the serum samples of two CHB subtype patients (LSSD and DHSM). Compared to healthy controls we found a number of proteins differentially expressed in both LSSD and DHSM CHB subtypes, such as actin, apolipoprotein, complement component, and immunoglobulin related proteins. In addition, we identified some proteins differentially expressed exclusively in one of LSSD and DHSM groups, such as gelsolin (GSN), likely SNC73 protein, and transient receptor potential cation channel subfamily M member 8 (TRPM8) that were found with different expression in LSSD-CHB patients only and transthyretin (TTR), tubulin, and keratin types I and II that were differentially expressed in DHSM-CHB patients only. Our findings not only validate previously reported CHB protein biomarkers but also report for the first time protein biomarkers for LSSD and DHSM CHB subtypes. The output of this study gives a valuable resource for future HBV associated studies and provides new insights of traditional Chinese medicine on molecular level.

2. Materials and Methods {#sec2}
========================

2.1. Ethics Statement {#sec2.1}
---------------------

This study was conducted in compliance with the Declaration of Helsinki, the ethics approval was granted by the research medical ethics committee of Chengdu University of Traditional Chinese Medicine, and signed informed consent was obtained from all participants.

2.2. Patients and Serum Collection {#sec2.2}
----------------------------------

A total of 104 CHB patients were enrolled from West China Hospital, Sichuan University, and filtered with strict clinical evaluation described below. For iTRAQ proteomics analysis, we obtained blood samples from 30 LSSD-CHB patients, 30 DHSM-CHB patients, and 20 healthy controls (HCTL). For western blot analysis, 9 LSSD-CHB patients, 9 DHSM-CHB patients, and 6 HCTL participants were enrolled. Serum was collected from blood sample (4 mL) following the manufacture\'s protocol. Briefly, blood sample was incubated at room temperature for 2 h in vacutainer blood handling tube (Becton Dickinson, New Jersey, USA) and centrifuged for 10 min at 3,000 rpm and 4°C. Serum sample, which is the result supernatant, was transferred into a clean polypropylene tube and stored at −80°C.

2.3. Clinical Evaluation {#sec2.3}
------------------------

The viral markers HBsAg, HBeAg, anti-HBs, anti-HBc, and anti-HBe were determined routinely in serum samples using standard procedures (AxSYM®; Abbott Laboratories, Rungis, France), as well as other molecular diagnostic markers like ALT (alanine transaminase), AST (aspartate aminotransferase), STB (serum total bilirubin), CB (conjugated bilirubin), UCB (unconjugated bilirubin), and HBV-DNA. Participants, who have hepatitis B history or HBsAg positive history for more than six months, were diagnosed as chronic HBV infection if they were positive to HBsAg and/or HBV-DNA. We used both western and Chinese medicine criteria to divide CHB patients into two groups. First, participants were satisfied with the following requirements: (1) serum HBsAg positive for over 6 months; (2) HBV-DNA positive; (3) continuous or repeated elevated serum ALT in last 12 months; (4) being 18\~60 years old; (5) no planed move during the test. Then, LSSD-CHB and DHSM-CHB patients were diagnosed using the clinical symptoms mentioned before. CHB patients were diagnosed as LSSD-CHB when they met the criteria: (1) Mi and Mii; (2) Mi, Sii, and Siii; (3) Mii and Si. DHSM-CHB patients were diagnosed as follows: (1) M1 and M2; (2) M1, S1, and S2; (3) M2 and two of the secondary symptoms. We also filtered the patients when they satisfied one of the following criteria: (1) being associated with other types of hepatitis viruses or human immunodeficiency virus (HIV); (2) cirrhosis, malignancy; (3) being diagnosed with fulminant hepatitis (including acute, subacute, and chronic severe hepatitis); (4) being associated with drug or toxic liver, autoimmune hepatitis, and genetic-metabolic liver disease; (5) heart, lung, kidney, endocrine, blood, and other serious diseases; (6) pregnant women and lactating women; (7) mental disorders, in line with Chinese Classification of Mental Disorders Diagnosis (CCMD-3) standard; (8) other individuals not suitable for the cohort study.

2.4. Protein Preparation {#sec2.4}
------------------------

Serum sample (200 *μ*L) from each patient was processed to reduce the complexity by using ProteoMiner™ Kits (Bio-Rad Laboratories, Hercules, CA, USA). Then, the sample was eluted using Lysis buffer at pH 8.5 (2M Thiourea, 7M Urea, 4% CHAPS, and 40 mM Tris-HCl), reduced using 10 mM DTT at 56°C for 1 h, and alkylated using 55 mM IAM in darkness for 1 h. After being precipitated within chilled acetone (4 × volume) at −20°C overnight, the protein sample was centrifuged at 30,000 ×g for 15 min at 4°C; the pellet was next dissolved in 500 *μ*L of 0.5 M triethylammonium bicarbonate (Applied Biosystems, Milan, Italy) and sonicated at 200 W in ice for 15 min. Finally, the samples were centrifuged again at 30,000 ×g for 15 min at 4°C, and the supernatant was quantified using Bradford Protein Assay Kit (CWBIO, Beijing, China) and stored at −80°C for subsequent analysis.

2.5. iTRAQ Sample Labelling, SCX Fractionation, and LC-ESI-MS/MS Analysis {#sec2.5}
-------------------------------------------------------------------------

Proteins isolated from 10 individuals in the same group were pooled for iTRAQ labelling. Pooled protein samples (100 *μ*g) were digested using Trypsin Gold (Promega, Madison, WI, USA) at 37°C for 16 h (protein: trypsin = 30 : 1). Digested peptides were dried by vacuum centrifugation, reconstituted in 0.5 M triethylammonium bicarbonate (Applied Biosystems, Milan, Italy), and processed 8-plex iTRAQ (Applied Biosystems) labelling following the protocols. Samples were labelled with the iTRAQ tags as follows: LSSD-CHB (113, 115, and 117), DHSM-CHB (114, 116, and 118), and HCTL (119 and 121). After being incubated at room temperature for 2 h, all the peptide mixtures were then pooled and dried by vacuum centrifugation. Strong cation exchange (SCX) chromatography was performed using the LC-20AB HPLC Pump system (Shimadzu, Kyoto, Japan), as previously described \[[@B18]\].

SFX fractions were resuspended in buffer A (2% ACN, 0.1% FA), followed by a centrifugation at 20,000 g for 10 min. Then, 10 *μ*L of the supernatant was loaded onto a 2 cm C18 trap column on a LC-20AD nanoHPLC (Shimadzu, Kyoto, Japan) by the autosampler and eluted onto a 10 cm analytical C18 column (inner diameter 75 *μ*m) packed in-house. At 300 nL/min the samples were loaded with buffer B (98% ACN, 0.1% FA) as the following procedural: 5% B for 1 min, a 44 min gradient from 2 to 35% B, a 2 min linear gradient to 80%, and 80% B for 4 min. Finally, the chromatographic conditions were restored in 1 min. Data acquisition was performed with an Q EXACTIVE (Thermo Fisher Scientific, San Jose, CA) coupled online to the HPLC, as described \[[@B19], [@B20]\].

2.6. Database Search and Protein Quantification {#sec2.6}
-----------------------------------------------

Database search and protein quantification were performed using Mascot (Matrix Science, London, UK; version 2.4.0). Briefly, raw data files acquired from the Orbitrap were converted into mascot generic format (MGF) files using msconvert tool of ProteoWizard (<http://proteowizard.sourceforge.net/>) \[[@B21]\]. To identify expressed proteins and quantify them, all 20 MGF files were merged and searched against UniProtHUMAN (2016_04, 152,544 sequences) database using Mascot with parameters: quantification: iTRAQ 8plex (Applied Biosystems iTRQA™ 8-plex); enzyme: trypsin; fixed modification: carboxymethyl (C), iTRAQ8plex (N-term) and iTRAQ8plex (K); variable modifications: dioxidation (M), oxidation (M), and iTRAQ8plex (Y), mass values: monoisotopic; peptide mass tolerance: ±15 ppm; fragment mass tolerance: ±20 mmu; max missed cleavages: (1) The charge states of peptides were set to +2 and +3. Specifically, an automatic decoy database search was performed in Mascot by choosing the decoy checkbox in which a random sequence of database is generated and tested for raw spectra as well as the real database. To reduce the probability of false peptide identification, only peptides at the 95% confidence interval by a Mascot probability analysis greater than "identity" were counted as identified. And each confident protein identification involves at least one unique peptide.

2.7. Protein Different Expression and Functional Analysis {#sec2.7}
---------------------------------------------------------

To identify differentially expressed proteins in LSSD-CHB and DHSM-CHB compared to HCTL, we set a cut-off for fold change (\>1.2) of protein abundance provided by Mascot and *p* value (\<0.05) calculated by edgeR \[[@B22]\]. Venn diagram of up- and downregulated proteins was analyzed by InteractiVenn (<http://www.interactivenn.net/>) \[[@B23]\]. To annotate potential functions of proteins, UniProt IDs of candidate proteins were submitted to DAVID Bioinformatics Resources 6.7 (<https://david.ncifcrf.gov/home.jsp>) \[[@B24]\] and STRING v10 (<http://string-db.org/>) \[[@B25]\], Gene Ontology (GO), and KEGG pathway were selected, and we used false discovery rate (FDR) to control the results. Protein-protein interaction networks were analyzed by STRING.

2.8. Western Blot Analysis {#sec2.8}
--------------------------

Protein samples obtained from serum of 9 LSSD-CHB patients, 9 DHSM-CHB patients, and 6 healthy individuals were resolved by 12% SDS-PAGE using Miniprotean II electrophoresis unit (Bio-Rad) run at constant 120 V for 1 h and transferred to a PVDF membrane (Amersham Biosciences) under a constant voltage of 15 V for 20 min. The membranes were blocked with 5% skim milk powder in Tris-buffered saline with 0.05% Tween-20 (TTBS) for 1 h and probed in TTBS with primary antibodies (1 : 500, Santa Cruz Biotechnology, CA, USA), anti-PSMA7 (sc-166761), anti-PF4V (sc-367359), anti-PSMA6 (sc-271187), anti-SERPING1 (sc-377062), anti-ACTB (sc-8432), anti-AHSG (sc-137102), anti-CTSC (sc-74590), anti-PLTP (sc-271596), and anti-ALB (sc-46293), followed by incubation with secondary antibody (1 : 1000) for 1 h in darkness. All antibody incubations were carried out using gentle orbital shaking at room temperature. Western blots were washed five times in TTBS (5 min × 2 and 10 min × 3) after each incubation step and visualized with enhanced chemiluminescence (ECL, GE Healthcare) following the manufacturers\' instructions. Band intensities on the Western blots were quantified using ImageJ (Wayne Rasband, National Institutes of Health). Albumin was used as reference to calculate the relative intensity of each protein. Then, mean ± SD values of each protein in HCTL and patients were calculated and compared using GraphPad Prism (<http://www.graphpad.com/>).

2.9. Statistical Analysis {#sec2.9}
-------------------------

Statistical analysis including the calculation of mean value, standard deviation (SD), and students\' *t*-test was performed by using GraphPad Prism (v 6.02). The Holm-Sidak method was used to calculate the statistical significance of multiple clinical diagnostic values.

3. Results {#sec3}
==========

3.1. Diagnosis of the Patients {#sec3.1}
------------------------------

To study serum protein biomarkers in LSSD and DHSM CHB patients, we obtained a total of 80 participants, including 30 LSSD-CHB, 30 DHSM-CHB patients, and 20 healthy volunteers. As shown in [Table 1](#tab1){ref-type="table"} and Table S1 in Supplementary Material available online at <http://dx.doi.org/10.1155/2016/3290260>, mean ages of LSSD-CHB, DHSM-CHB, and HCTL were 30, 36.8, and 35.5 years, respectively. Except missing information of three, all patients were positive to HBsAg and anti-HBc. There were two LSSD-CHB patients positive to anti-HBs, and 9 LSSD-CHB and 12 DHSM-CHB patients positive to anti-HBe. HBV-DNA levels in the blood samples of LSSD-CHB and DHSM-CHB patients were ranged from 5.12*E* + 03\~1.12*E* + 08 IU/mL and 6.34*E* + 04\~9.40*E* + 08 IU/mL, respectively. It is interesting that hepatitis B viral load (HBV-DNA copies) was significantly different (*p* = 0.0096) in LSSD-CHB and DHSM-CHB patients. Next, we examined ALT, AST, STB, CB, and UCB levels in the blood samples of CHB patients. Mean values of these diagnosis biomarkers in the blood samples of LSSD-CHB and DHSM-CHB patients were similar. In addition, the levels of ALT and AST remained at a high level, compared to healthy individuals \[[@B26], [@B27]\], which confirmed their CHB infection.

3.2. Protein Identification and Quantification by iTRAQ {#sec3.2}
-------------------------------------------------------

Next, we quantified the serum proteins in these LSSD-CHB and DHSM-CHB patients using iTRAQ. Initially, a total of 371,034 spectra were generated by liquid chromatography coupled to mass spectrometry (LC-MS/MS) analysis. Of them, 98,243 spectra (5,591 unique peptides) were aligned to 842 proteins from 666 families. The mass distribution of identified proteins ([Figure 1(a)](#fig1){ref-type="fig"}) suggested by Mascot revealed 170 (98.69%) were above 10 kDa, of which 170 (20.19%) and 141 (16.75%) were 10 to 20 kDa and above 100 kDa, respectively. We also counted the proteins aligned with significant peptides, shown in [Figure 1(b)](#fig1){ref-type="fig"}, and 547 (64.96%) proteins were aligned by two and more peptides. In addition, the distribution of protein sequence coverage is shown in [Figure 1(c)](#fig1){ref-type="fig"}. Protein sequence coverage with 40\~100%, 30\~40%, 20\~30%, 10\~20%, and under 10% variation accounted for 8.79%, 14.25%, 17.70%, 23.28%, and 35.99%, respectively. In [Figure 1(d)](#fig1){ref-type="fig"}, we showed correlation between two samples and found LSSD-CHB samples were closer to DHSM-CHB samples than HCTL.

3.3. Identification of Differentially Expressed Proteins {#sec3.3}
--------------------------------------------------------

Differentially expressed proteins were defined as those showed greater than 1.2-fold change in relative abundance and a *p* value \< 0.05. Compared to HCTL we identified a total of 392 proteins differentially expressed (Table S2), of which 273 were identified in LSSD-CHB group and 345 in DHSM-CHB group. As shown in the volcano plots, we identified 172 upregulated and 101 downregulated proteins in LSSD-CHB group ([Figure 2(a)](#fig2){ref-type="fig"}) and 199 upregulated and 146 downregulated proteins in DHSM-CHB group ([Figure 2(b)](#fig2){ref-type="fig"}), compared to HCTL group. Venn diagram ([Figure 2(c)](#fig2){ref-type="fig"}) revealed LSSD-CHB and DHSM-CHB shared 142 upregulated and 84 downregulated proteins; 30 and 57 proteins were exclusively upregulated in LSSD-CHB and DHSM-CHB, respectively; 17 and 62 proteins were exclusively downregulated in LSSD-CHB and DHSM-CHB, respectively; and no protein was identified with upregulation in one CHB subtype but with downregulation in another.

3.4. Potential Biomarkers for CHB {#sec3.4}
---------------------------------

The identification of proteins differentially expressed in LSSD-CHB and DHSM-CHB groups relative to the HCTL group was of interest as these could provide leads for potentially useful diagnostic and prognostic biomarkers. First, we examined those 142 commonly upregulated and 84 commonly downregulated proteins. As shown in [Table 2](#tab2){ref-type="table"}, the largest upregulated protein family was immunoglobulin related protein, showing 20 upregulated and 3 downregulated proteins identified. In clinical immunology, levels of immunoglobulins especially IgG can be used to characterize viral hepatitis in patients \[[@B28], [@B29]\]. Four IgG subclasses (IgG1 to IgG4) differ in their heavy chain constant regions and have different effects on virus-cell fusion inhibition, virus neutralization, and overall course of infection, as have been reported for various viruses including HIV \[[@B30]\] and HBV \[[@B31]\]. Highly expressed proteins encoding heavy chains for immunoglobulins including IGHG1, IGHG3, IGHG4, and IGH@ have been reported with upregulation in HBV \[[@B32], [@B33]\] and HCC patients \[[@B34]\]. Other upregulated protein families such as heat shock protein, histone, ras-related protein, and von Willebrand factor identified in current study have also been reported in patients infected by HBV or hepatitis C virus (HCV) \[[@B35]--[@B38]\]. The largest downregulated protein family was complement, 15 complement proteins downregulated in LSSD-CHB with 0.82- to 0.37-fold change and in DHSM-CHB with 0.77- to 0.31-fold change. Other protein families like insulin-like growth factor binding protein and serum amyloid protein were also decreased in CHB patients in comparison to HCTL group. In addition, several known upregulated proteins from other families in patients infected by HBV or HCV ([Table 2](#tab2){ref-type="table"}), such as apolipoproteins (APOA2, APOB, and APOB-variant) \[[@B39], [@B40]\], A2M (alpha-2-macroglobulin) \[[@B41]\], alpha-actinin-3 (ACTN3) \[[@B42], [@B43]\], vimentin (VIM) \[[@B38]\], and putative uncharacterized proteins (DKFZp686N02209 and DKFZp686I04196) \[[@B34], [@B44], [@B45]\], were identified in LSSD-CHB and DHSM-CHB groups. The different expression of proteins in the serum of CHB patients indicates they may have functions in response of HBV and CHB processing and can be used as biomarkers in clinical diagnosis.

We next analyzed the potential functions of commonly differentially expressed serum proteins in LSSD-CHB and DHSM-CHB groups using DAVID Bioinformatics Resources 6.7 \[[@B24]\] and STRING v10 \[[@B25]\]. Cellular component annotation ([Figure 3(a)](#fig3){ref-type="fig"}) showed 63 and 7 proteins were "extracellular region" (GO: 0005576, GO: 0005615, and GO: 0044421) and "lipids" (GO: 0032994 and GO: 0034358), respectively. However biological process annotation ([Figure 3(b)](#fig3){ref-type="fig"}) showed most of the differentially expressed proteins associated with immune response, including "acute inflammatory response" (GO: 0002526), "response to wounding" (GO: 0009611), "inflammatory response" (GO: 0006954), "complement activation" (GO: 0006956), "defense response" (GO: 0006952), "humoral immune response mediated by circulating immunoglobulin" (GO: 0002455), "immune effector process" (GO: 0002252), "B cell mediated immunity" (GO: 0019724), and "activation of immune response" (GO: 0002253). It has been well studied that immunological events are necessary to control hepatitis B virus (HBV) infection \[[@B46], [@B47]\]. In addition, KEGG pathway analysis also showed differentially expression proteins function mainly in the pathways of "complement and coagulation cascades" (hsa04610), "systemic lupus erythematosus" (hsa05322), "focal adhesion" (hsa04510), and "viral carcinogenesis" (hsa05203). Overall, differentially expressed proteins in both LSSD-CHB and DHSM-CHB groups have potential ability to be used as biomarkers.

3.5. Dysregulated Proteins Detected Exclusively in LSSD-CHB and DHSM-CHB {#sec3.5}
------------------------------------------------------------------------

Next, we examined differentially expressed proteins exclusively in LSSD-CHB and DHSM-CHB groups. A total of 30 upregulated and 17 downregulated proteins were specifically identified in LSSD-CHB patient serum samples ([Table 3](#tab3){ref-type="table"}). Among them 11 upregulated immunoglobulin related proteins, gelsolin (GSN), serum paraoxonase/lactonase 3 (PON3), likely SNC73 protein, transient receptor potential cation channel subfamily M member 8 (TRPM8), and several uncharacterized proteins (DKFZp686M08189, DKFZp686C02220, and DKFZp686K04218) attracted our attention due to their high abundance. Serum PON3 concentrations have been reported to increase in patients with CHB or cirrhosis and showed significant direct correlations with the degree of periportal abnormalities including fibrosis and with serum FAS (a marker of antiapoptosis) concentrations \[[@B48]\]; however, serum gelsolin level has been reported to reduce significantly in patients with acute liver failure (47%), myocardial infarction (69%), sepsis (51%), and myonecrosis (66%) \[[@B49]\]. Among the specifically downregulated serum proteins in LSSD-CHB patients fibulin-1 (FBLN1) is a tumor suppressor in hepatocellular carcinoma \[[@B50]\]. Proteins specifically differentially expressed in LSSD-CHB patients were predicted to function mainly in biological processes of "protein activation cascade" (GO: 0072376), "regulation of response to wounding" (GO: 1903034), "blood coagulation, fibrin clot formation" (GO: 0072378), "negative regulation of response to stimulus" (GO: 0048585), and "acute-phase response" (GO: 0006953).

We also identified 57 upregulated and 62 downregulated proteins exclusively in DHSM-CHB patients ([Table 4](#tab4){ref-type="table"}). Two IGL@ proteins (Q6GMX4_HUMAN and Q6PIQ7_HUMAN) were specifically upregulated in DHSM-CHB patients with 1.27-fold change. Transthyretin (TTR), upregulated 1.34-fold in DHSM-CHB, can be induced by hepatitis C virus and activate TGF-*β* signaling pathway with furin \[[@B51]\]. Interestingly, we found three members of tubulin (TUBA4A, TUBB1, and TUBB8) were upregulated only in DHSM-CHB patients compared with HCTL. Although there are few reports about tubulin and HBV, it is well known that 42 kDa tubulin alpha-6 chain fragment in well-differentiated hepatocellular carcinoma tissues is from patients infected with HCV \[[@B52]\]. In addition, we found actinin, alpha 1 (ACTN1), which can directly interact with HCV \[[@B53]\], GAPDH, which can bind to the HBV posttranscriptional regulatory element \[[@B54]\], and polymeric immunoglobulin receptor (PIGR), the main transporter of IgA \[[@B55]\], were upregulated in DHSM-CHB but not in LSSD-CHB. Among DHSM-CHB specifically downregulated proteins we identified three members of keratin type I (KRT9, KRT10, and KRT14) and another three members of keratin type II (KRT1, KRT2, and KRT6B). Although there is no evidence showing relation between these six keratin proteins with CHB or other liver diseases, variant keratins are associated with progression of fibrosis during chronic hepatitis C infection \[[@B56]\]. Differentially expressed proteins exclusively detected in DHSM-CHB patients were predicted to be involved in the biological processes of "immune system process" (GO: 0002376), "response to stress" (GO: 0006950), "defense response" (GO: 0006952), "immune response" (GO: 0006955), and "single-organism metabolic process" (GO: 0044710).

Compared to HCTL group up- and downregulated proteins exclusively in LSSD-CHB and DHSM-CHB patients showed their potential ability of being biomarkers for these two subtypes of HBV induced CHB. Some of them have been reported in other studies; however, more experiments need to be performed to investigate their functions and validate their specificity and accuracy in clinical trials.

3.6. Validation of the Quantitative Proteomic Analysis {#sec3.6}
------------------------------------------------------

To validate the results obtained by proteomics analysis, eight randomly selected proteins and internal control albumin with altered expression profile were monitored by western blotting in an independent group of samples. Figures [4(a)](#fig4){ref-type="fig"} and [4(b)](#fig4){ref-type="fig"} showed the western blots for eight proteins and internal control albumin. PSMA6 (20S proteasome alpha6), PSMA7 (20S proteasome alpha7/alpha8) were upregulated and PF4 V (platelet factor 4 variant) was downregulated in LSSD-CHB group compared to HCTL ([Figure 4(c)](#fig4){ref-type="fig"}). Except SERPING1 (plasma protease C1 inhibitor), AHSG (fetuin-A), ACTB (actin), CTSC (cathepsin C), and PLTP (phospholipid transfer protein) were upregulated in the serum of DHSM-CHB patients ([Figure 4(d)](#fig4){ref-type="fig"}). Although the difference between patients and healthy participants was not significant by western blotting analysis, their regulations in patients and healthy group were consistent with iTRAQ. The original images of western blots (see Figure S1) might contain some differences due to brightness and contrast settings.

4. Discussion {#sec4}
=============

Quantitation of serum or plasma proteins using comparative proteomics has recently been suggested as a suitable approach for the detection of liver disease biomarkers \[[@B17], [@B57]--[@B59]\]. The iTRAQ technology has been proposed as a powerful alternative to common tools (e.g., ELISA) and a flurry of applications emerged in the literature.

In this study, iTRAQ LC--MS/MS proteomics was used to detect serum protein as biomarkers of LSSD-CHB and DHSM-CHB patients. We compared the proteomics profile of LSSD-CHB and DHSM-CHB patients with healthy individuals and indicated 142 upregulated and 84 downregulated proteins shared by these two CHB subtype diseases. Protein-protein interaction network ([Figure 5](#fig5){ref-type="fig"}) showed several significant proteins might function in response to HBV, such as actins (ACTA2, ACTB, ACTBL2, ACTN3, and ACTN4), apolipoproteins (APOA2, APOA5, APOB, APOC3, and APOC4), heat shock proteins (HSP90AA1 and HSP90AB1), and proteasome subunit proteins (PSMA1 and PSMA4). It has been reported that HBV core proteins can interact with the C-terminal region of actin-binding protein \[[@B60]\] and HBV X protein (HBx) can block filamentous actin bundles by interaction with eEF1A1 (eukaryotic translation elongation factor 1 alpha 1) \[[@B61]\]. In addition, ACTA2 is a marker of hepatitis stellate cells and correlated significantly with necroinflammatory grades and fibrotic stages in CHB or CHC \[[@B13]\]. Apolipoproteins are supposed to enhance the infectivity of hepatitis virus during the infection \[[@B39], [@B62]\] and are identified to interact with HBx as well \[[@B63]\]. Among the apolipoproteins APOA2 is a considerable biomarker because its expression is increased on both mRNA and protein levels in CHB patients \[[@B14], [@B64]\]. HBx protein also interacts with heat shock proteins and enhances HBx-mediated apoptosis \[[@B65]\]. A HBV-specific peptide (TVATAMG) is associated with heat shock protein and has potential for engineering tumor vaccines against hepatocellular carcinoma and chronic HBV infection \[[@B66]\]. Heat shock proteins like HSP27, HSP90, and GRP78 are upregulated in HBV related hepatocellular carcinoma, associated with vascular invasion and intrahepatic metastasis and have potential to be prognosis markers \[[@B67], [@B68]\]. Commonly downregulated complement proteins are important mediators of inflammation and contribute to the regulation of the immune response. C4, a predisposing factor to autoimmune chronic active hepatitis \[[@B69]\], is expressed lowly in chronic hepatitis C patient compared to that in controls \[[@B70]\]. Low serum levels of complement in viral hepatitis are associated with high titers of hepatitis-associated antigen \[[@B71]\]. It is said that complement proteins are related to hepatitis B vaccine and C4AQ0 (mutant C4) probably contribute to inefficient complement activation and failure of B cells to secret anti-HBs \[[@B72]\]. Our results confirmed the potential of previously reported proteins in diagnosis of patients infected by HBV.

LSSD-CHB and DHSM-CHB are two subtypes of CHB according to traditional Chinese medicine pattern classification. In this study we identified 47 and 119 differentially expressed proteins exclusively in LSSD-CHB and DHSM-CHB, respectively, which could be used as biomarkers for LSSD-CHB and DHSM-CHB patients. We showed top 5 highly expressed proteins with different expression in LSSD-CHB and DHSM-CHB patients compared to HCTL group in [Figure 6](#fig6){ref-type="fig"}. Using relative expression ratio calculated by MASCOT we found mean expression levels of some proteins were close in LSSD-CHB and DHSM-CHB but with different *p* values, such as CFH (complement factor H), F2 (prothrombin), and FGA (fibrinogen alpha chain). As we know, prothrombin time is one of the markers of liver test; it is usually lower in HBV infected patients than in healthy people and a good marker for liver fibrosis \[[@B73], [@B74]\]. CFH functions as a cofactor in the inactivation of C3b by factor I \[[@B75]\], which can interact with IgG and is moderately depressed in the serum of patients with viral hepatitis \[[@B71]\]. FGA has a major function in hemostasis as one of the primary components of blood clots \[[@B76]\]. Fibrinogen-like protein 2 (FGL2) has been identified as a potential biomarker for severity of CHC infection \[[@B77]\]. Other proteins also have been reported to be associated with HBV infection. LGALS3BP (lectin galactoside-binding soluble 3 binding protein isoform 1) were downregulated in LSSD-CHB patients (fc = 0.71, *p* value = 2.49*E* − 06) and DHSM-CHB patients (fc = 0.89, *p* value = 0.061). Previous studies about LGALS3BP in CHB and HCC found its different expression on transcriptional level \[[@B78]\], while in current study we identified its protein was differentially expressed in CHB patients and had the potential to be a good marker for LSSD-CHB subtype. PON3 (serum paraoxonase/lactonase 3), which was upregulated exclusively in LSSD-CHB, might play a hepatoprotective role against histological alterations and hepatic cell apoptosis leading to liver disease \[[@B48]\].

DHSM-CHB specifically differentially expressed proteins like ITIH1 (inter-alpha-trypsin inhibitor heavy chain H1), THBS1 (thrombospondin-1), C5 (Complement C5), and ALB (albumin) have been also reported in hepatitis viral related diseases. The expression level of ITIH1 in HCTL group was similar to that in LSSD-CHB patients (fc = 0.99, *p* value = 0.227) but was downregulated significantly in DHSM-CHB patients (fc = 0.81, *p* value = 0.012). The low expression of ITIH1 indicated it can be used to differ DHSM-CHB from LSSD-CHB. In addition, it has been experimented to be downregulated in HCV infected patients \[[@B79]\] and hepatitis C associated hepatocellular carcinoma patients \[[@B80]\]. It is reported that HCV viral proteins act directly or indirectly on THBS1 in TGF-*β* pathway \[[@B81]\]. By noninvasive imaging the gene expression of THBS1 was upregulated in liver cancer \[[@B82]\]. Interestingly, ALB has been reported as an important factor to score the risk of HCC in CHB patients \[[@B83]\]. In our study, ALB was downregulated in both CHB subtypes but significantly exclusively in DHSM-CHB. Our results confirmed its different expression in CHB patients and revealed that the criteria of ALB expression in CHB patients required more patients and experiments.

Due to the fact that hepatitis B viral load in DHSM-CHB patients was significantly higher than that in LSSD-CHB patients, we assume HBV-DNA might be related to CHB patients with different syndromes and it requires further experiments. To our knowledge, this study appears to be the first iTRAQ based approach aimed at identifying leads for potential useful biomarkers of patients of CHB subtypes. The candidates identified in this study await rigorous clinical validation using large cohorts of patient samples and more experimental function analysis.
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###### 

Liver function test and hepatitis B test were performed for all the volunteers in this study and the results can be seen in Table S1. Using iTRAQ proteomics technology, we identified a total of 842 proteins in LSSD-CHB, DHSM-CHB patients and healthy individuals. Compared to healthy individuals, we identified a total of 392 proteins differentially expressed in these two CHB subtypes, of which they shared 142 up-regulated and 84 down-regulated proteins. The full list of differentially expressed proteins and the statistical values can be seen in Table S2. Further, we used western blotting analysis to validate the expression of differentially expressed proteins and the original images of western can be seen in Figure S1.
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![Identification and analysis of serum proteome of CHB infected patients. (a) Distribution of protein mass of identified proteins. (b) Number of peptides that match to proteins as indicated by MASCOT 2.4.0. (c) Coverage of identified proteins in CHB patient serum. (d) Correlation between samples calculated by corrplot.](BMRI2016-3290260.001){#fig1}

![Identification of differentially expressed proteins in LSSD-CHB and DHSM-CHB patients compared with HCTL. (a) Volcano plot of differentially expressed proteins between LSSD-CHB and HCTL groups. (b) Volcano plot of differentially expressed proteins between DHSM-CHB and HCTL groups. (c) Venn diagram of up- and downregulated proteins in LSSD-CHB and DHSM-CHB groups.](BMRI2016-3290260.002){#fig2}

![Gene Ontology annotation for shared differentially expressed proteins in LSSD- and DHSM-CHB groups: (a) cellular component, (b) biological process.](BMRI2016-3290260.003){#fig3}

![Western blot analysis. (a) Western blot analysis for PSMA7, PSMA6, and PF4 V in LSSD-CHB patients. (b) Western blot analysis for AHSG, ACTB, CTSC, PLTP, and SERPING1 in DHSM-CHB patients. Box plots of the relative intensity of candidate proteins in LSSD-CHB (c) and DHSM-CHB (d) groups.](BMRI2016-3290260.004){#fig4}

![Protein-protein interaction network of commonly differentially expressed proteins in LSSD-CHB and DHSM-CHB patients compared with HCTL group.](BMRI2016-3290260.005){#fig5}

![Top 5 highly expressed proteins differentially expressed in LSSD-CHB and DHSM-CHB compared to HCTL. Fold changes (fc) and *p* values (*p*) of them were shown in red and blue for LSSD-CHB and DHSM-CHB, respectively.](BMRI2016-3290260.006){#fig6}

###### 

Clinical diagnosis of patients who participated in this study.

  Diagnosis                                 Unit     LSSD-CHB (*n* = 30)          DHSM-CHB (*n* = 30)          HCTL (*n* = 20)   *p* value
  ----------------------------------------- -------- ---------------------------- ---------------------------- ----------------- -----------
  *Sex*                                                                                                                           
  Male                                               24                           15                           10                 
  Female                                             6                            15                           10                 
                                                                                                                                 
  *Age*                                     Years    17\~56                       18\~60                       24\~56             
  Mean age                                  30.8     36.83                        36.15                                          
  Standard deviation (SD)                   10.526   11.885                       11.554                                         
                                                                                                                                 
  *Hepatitis B surface antigen (HBsAg)*                                                                                           
  Positive                                           28                           29                                              
  Negative                                           0                            0                                               
                                                                                                                                 
  *Hepatitis surface antibody (anti-HBs)*                                                                                         
  Positive                                           2                            0                                               
  Negative                                           25                           29                                              
                                                                                                                                 
  *Hepatitis Be antigen (HBeAg)*                                                                                                  
  Positive                                           21                           19                                              
  Negative                                           7                            9                                               
                                                                                                                                 
  *Hepatitis Be antibody (anti-HBe)*                                                                                              
  Positive                                           9                            12                                              
  Negative                                           19                           16                                              
                                                                                                                                 
  *Hepatitis B core antibody (anti-HBc)*                                                                                          
  Positive                                           28                           29                                              
  Negative                                           0                            0                                               
                                                                                                                                 
  *Alanine transaminase (ALT)*              IU/L     13.8\~627                    34\~673                                        1.0
  Mean ALT level                                     190.153                      187.393                                         
  SD                                                 161.231                      177.618                                         
                                                                                                                                 
  *Aspartate aminotransferase (AST)*        IU/L     26.5\~345                    28\~556                                        0.9999
  Mean AST                                           96.74                        142.427                                         
  SD                                                 71.699                       153.539                                         
                                                                                                                                 
  *Serum total bilirubin (STB)*             umol/L   10.1\~48.63                  6.5\~109.5                                     1.0
  Mean STB                                           19.208                       20.643                                          
  SD                                                 8.926                        18.127                                          
                                                                                                                                 
  *Conjugated bilirubin (CB)*               umol/L   2.4\~16.4                    2.3\~99.2                                      1.0
  Mean CB                                            6.923                        9.408                                           
  SD                                                 3.542                        17.208                                          
                                                                                                                                 
  *Unconjugated bilirubin (UCB)*            umol/L   6\~34.13                     3.3\~29.3                                      1.0
  Mean UCB                                           12.284                       11.182                                          
  SD                                                 5.951                        4.921                                           
                                                                                                                                 
  *HBV-DNA*                                 IU/mL    5.12*E* + 03\~1.12*E* + 08   6.34*E* + 04\~9.40*E* + 08                     0.0096
  Mean HBV-DNA                                       2.521*E* + 07                5.655*E* + 07                                   
  SD                                                 3.221*E* + 07                1.717*E* + 08                                   

###### 

Commonly up- and downregulated proteins in LSSD-CHB and SSDHS-CHB groups (part).

  Family                                       UniProt_ID         Gene_name                                                                                      Description                                                                    Number of significant matches   Number of significant sequences   emPAI   LSSD-CHB versus HCTL   SSDHS-CHB versus HCTL                  
  -------------------------------------------- ------------------ ---------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------ ------------------------------- --------------------------------- ------- ---------------------- ----------------------- -------------- --------------
  Immunoglobulin related proteins              A0A087WV47_HUMAN   IGHG1                                                                                          Ig gamma-1 chain C region                                                      1541                            14                                5.37    1.84                   6.30*E* − 05            1.47           2.71*E* − 04
  A0A087WYC5_HUMAN                             IGHG1              Ig gamma-1 chain C region                                                                      1501                                                                           14                              4.82                              1.87    3.51*E* − 05           1.48                    1.69*E* − 04   
  A0A087X1C7_HUMAN                             IGHG1              Ig gamma-1 chain C region                                                                      1511                                                                           13                              4.79                              1.84    6.12*E* − 05           1.47                    2.60*E* − 04   
  A0A087WXL8_HUMAN                             IGHG3              Ig gamma-3 chain C region                                                                      739                                                                            11                              2.07                              1.84    5.45*E* − 05           1.47                    1.12*E* − 04   
  A0A0G2JPD4_HUMAN                             IGHG4              Ig gamma-4 chain C region (fragment)                                                           31                                                                             6                               1.56                              1.69    6.47*E* − 04           1.24                    4.12*E* − 02   
  KV112_HUMAN                                                     Ig kappa chain V-I region Kue                                                                  2                                                                              2                               0.53                              1.82    1.39*E* − 03           1.51                    9.53*E* − 04   
  KV311_HUMAN                                                     Ig kappa chain V-III region IARC/BL41                                                          2                                                                              1                               0.49                              1.61    5.86*E* − 03           1.28                    1.64*E* − 02   
  LV302_HUMAN                                                     Ig lambda chain V-III region LOI                                                               25                                                                             3                               4.01                              1.73    1.75*E* − 04           1.35                    8.79*E* − 04   
  LV301_HUMAN                                                     Ig lambda chain V-III region SH                                                                6                                                                              1                               0.61                              1.99    1.59*E* − 07           1.56                    5.32*E* − 07   
  S6B2B6_HUMAN                                                    IgG H chain                                                                                    384                                                                            3                               0.6                               2.05    1.06*E* − 04           1.57                    9.46*E* − 04   
  S6BAM6_HUMAN                                                    IgG H chain                                                                                    389                                                                            4                               0.9                               2.05    4.60*E* − 05           1.56                    5.55*E* − 04   
  S6BGE0_HUMAN                                                    IgG H chain                                                                                    394                                                                            4                               1.13                              2.04    4.84*E* − 05           1.56                    6.39*E* − 04   
  S6C4S4_HUMAN                                                    IgG H chain                                                                                    384                                                                            3                               0.73                              2.05    9.63*E* − 05           1.57                    5.91*E* − 04   
  S6C4R7_HUMAN                                                    IgG L chain                                                                                    257                                                                            6                               6.68                              1.53    2.61*E* − 02           1.27                    4.54*E* − 02   
  Q6GMX6_HUMAN                                 IGH@               IGH@ protein                                                                                   1524                                                                           14                              6.04                              1.83    6.27*E* − 05           1.46                    3.15*E* − 04   
  A0A0F7TC28_HUMAN                             IGHV4-4            IGHV4-4 protein (fragment)                                                                     3                                                                              2                               1.27                              1.49    9.67*E* − 03           1.24                    2.27*E* − 02   
  Q5FWF9_HUMAN                                 IGL@               IGL@ protein                                                                                   143                                                                            6                               6.03                              1.60    1.35*E* − 02           1.32                    2.83*E* − 02   
  Q6PIK1_HUMAN                                 IGL@               IGL@ protein                                                                                   197                                                                            5                               4.45                              1.59    1.37*E* − 02           1.29                    4.62*E* − 02   
  Q9UL84_HUMAN                                                    Myosin-reactive immunoglobulin heavy chain variable region (fragment)                          6                                                                              3                               1.69                              1.52    1.58*E* − 02           1.46                    2.04*E* − 04   
  Q9UL79_HUMAN                                                    Myosin-reactive immunoglobulin light chain variable region (fragment)                          2                                                                              1                               0.57                              0.65    6.56*E* − 04           0.50                    1.93*E* − 12   
  A0A0C4DH33_HUMAN                             IGHV1-24           Protein IGHV1-24 (fragment)                                                                    5                                                                              2                               0.84                              0.82    5.43*E* − 03           0.81                    1.38*E* − 02   
  A0A0A0MT74_HUMAN                             IGKV1-16           Protein IGKV1-16 (fragment)                                                                    5                                                                              1                               0.9                               1.58    3.55*E* − 03           1.26                    3.22*E* − 02   
  A0A075B6I9_HUMAN                             IGLV7-46           Protein IGLV7-46 (fragment)                                                                    31                                                                             3                               1.41                              1.54    9.85*E* − 03           1.36                    2.46*E* − 03   
                                                                                                                                                                                                                                                                                                                                                                                        
  Complement                                   B7Z1F8_HUMAN                                                                                                      cDNA FLJ53025, highly similar to complement C4-B                               2230                            12                                56.68   0.78                   1.27*E* − 03            0.77           2.33*E* − 03
  B4E3S6_HUMAN                                                    cDNA FLJ58413, highly similar to complement component C7                                       63                                                                             10                              1.74                              0.55    8.69*E* − 10           0.50                    8.03*E* − 15   
  A8K2T4_HUMAN                                                    cDNA FLJ78207, highly similar to human complement protein component C7 mRNA                    86                                                                             15                              1.31                              0.55    1.62*E* − 09           0.50                    2.39*E* − 13   
  B2RA39_HUMAN                                                    cDNA, FLJ94686, highly similar to *Homo sapiens* complement factor H-related 5 (CFHL5), mRNA   35                                                                             5                               0.51                              0.54    7.03*E* − 12           0.57                    1.44*E* − 11   
  CO4A_HUMAN                                   C4A                Complement C4-A                                                                                5889                                                                           65                              21.28                             0.79    2.87*E* − 03           0.75                    7.70*E* − 04   
  CO4B_HUMAN                                   C4B                Complement C4-B                                                                                5983                                                                           66                              23.03                             0.79    2.95*E* − 03           0.74                    5.91*E* − 04   
  A0A024R035_HUMAN                             C9                 Complement component 9, isoform CRA_a                                                          225                                                                            17                              5.12                              0.67    1.36*E* − 05           0.54                    6.61*E* − 13   
  CO6_HUMAN                                    C6                 Complement component C6                                                                        92                                                                             12                              0.83                              0.50    3.34*E* − 12           0.48                    4.06*E* − 15   
  CO8A_HUMAN                                   C8A                Complement component C8 alpha chain                                                            66                                                                             8                               1.51                              0.66    1.94*E* − 06           0.53                    8.36*E* − 15   
  F5GY80_HUMAN                                 C8B                Complement component C8 beta chain                                                             133                                                                            16                              3.28                              0.65    6.59*E* − 07           0.61                    1.07*E* − 09   
  CO8G_HUMAN                                   C8G                Complement component C8 gamma chain                                                            41                                                                             8                               6.86                              0.61    8.80*E* − 08           0.50                    3.38*E* − 14   
  B1AKG0_HUMAN                                 CFHR1              Complement factor H-related protein 1                                                          216                                                                            6                               4.26                              0.66    1.30*E* − 06           0.75                    4.80*E* − 04   
  FHR3_HUMAN                                   CFHR3              Complement factor H-related protein 3                                                          45                                                                             6                               1.19                              0.82    7.05*E* − 03           0.77                    2.36*E* − 03   
  FHR4_HUMAN                                   CFHR4              Complement factor H-related protein 4                                                          31                                                                             3                               0.41                              0.37    3.90*E* − 23           0.31                    1.62*E* − 44   
  A0A0S2Z4I5_HUMAN                             CFP                Complement factor properdin isoform 1 (fragment)                                               13                                                                             2                               0.17                              0.58    2.21*E* − 11           0.72                    2.90*E* − 05   
                                                                                                                                                                                                                                                                                                                                                                                        
  Apolipoprotein                               APOA2_HUMAN        APOA2                                                                                          Apolipoprotein A-II                                                            421                             2                                 1.84    1.48                   4.64*E* − 02            1.26           3.72*E* − 02
  A0A0B4RUS7_HUMAN                             APOA5              Apolipoprotein A-V, isoform CRA_a                                                              15                                                                             7                               1                                 0.73    2.03*E* − 05           0.62                    2.95*E* − 08   
  E1B4S9_HUMAN                                 APOB               Apolipoprotein B (fragment)                                                                    129                                                                            7                               10.94                             1.97    1.23*E* − 05           1.53                    9.70*E* − 05   
  C0JYY2_HUMAN                                 APOB               Apolipoprotein B (including Ag(X) antigen)                                                     5227                                                                           215                             21.89                             1.84    2.08*E* − 04           1.44                    1.07*E* − 03   
  Q59HB3_HUMAN                                                    Apolipoprotein B variant (fragment)                                                            1661                                                                           69                              16.33                             1.85    2.79*E* − 04           1.41                    1.40*E* − 03   
  B0YIW2_HUMAN                                 APOC3              Apolipoprotein C-III                                                                           577                                                                            5                               8.48                              0.66    1.44*E* − 05           0.55                    3.02*E* − 09   
  APOC4_HUMAN                                  APOC4              Apolipoprotein C-IV                                                                            26                                                                             5                               3.84                              0.80    1.35*E* − 03           0.60                    8.22*E* − 09   
                                                                                                                                                                                                                                                                                                                                                                                        
  Histone                                      H15_HUMAN          HIST1H1B                                                                                       Histone H1.5                                                                   4                               2                                 0.35    2.02                   8.32*E* − 06            1.72           1.02*E* − 04
  A0A024R017_HUMAN                             HIST1H2AC          Histone H2A                                                                                    21                                                                             4                               2.27                              4.67    1.78*E* − 28           3.63                    4.54*E* − 33   
  C9J0D1_HUMAN                                 H2AFV              Histone H2A                                                                                    13                                                                             3                               1.11                              4.84    3.09*E* − 29           3.73                    2.99*E* − 37   
  A0A024QZZ7_HUMAN                             HIST1H2BD          Histone H2B                                                                                    12                                                                             4                               1.15                              4.58    1.39*E* − 29           3.38                    6.00*E* − 31   
  B2R4P9_HUMAN                                 H3F3A              Histone H3                                                                                     9                                                                              3                               0.88                              4.98    5.44*E* − 32           3.72                    9.13*E* − 39   
  Q5TEC6_HUMAN                                 HIST2H3PS2         Histone H3                                                                                     4                                                                              3                               0.6                               2.59    1.10*E* − 08           1.87                    3.39*E* − 06   
  B2R4R0_HUMAN                                 HIST1H4J           Histone H4                                                                                     39                                                                             5                               13.27                             4.47    3.83*E* − 35           3.41                    3.84*E* − 45   
                                                                                                                                                                                                                                                                                                                                                                                        
  Heat shock protein                           A0A024RD80_HUMAN   HSP90AB1                                                                                       Heat shock protein 90 kDa alpha (cytosolic), class B member 1, isoform CRA_a   12                              6                                 0.31    1.46                   3.59*E* − 02            1.51           2.77*E* − 05
  HS90A_HUMAN                                  HSP90AA1           Heat shock protein HSP 90-alpha                                                                28                                                                             10                              0.55                              1.58    5.45*E* − 03           1.65                    3.81*E* − 07   
                                                                                                                                                                                                                                                                                                                                                                                        
  Insulin-like growth factor binding protein   C1K3N3_HUMAN       IGFBP1                                                                                         Insulin-like growth factor binding protein 1 (fragment)                        3                               2                                 0.22    0.61                   2.62*E* − 07            0.60           5.40*E* − 09
  A0A024R1U8_HUMAN                             IGFBP4             Insulin-like growth factor binding protein 4, isoform CRA_a                                    2                                                                              1                               0.1                               0.66    8.52*E* − 06           0.66                    1.00*E* − 06   
  A0A024R433_HUMAN                             IGFBP5             Insulin-like growth factor binding protein 5, isoform CRA_a                                    3                                                                              2                               0.18                              0.83    3.37*E* − 03           0.80                    4.98*E* − 02   
                                                                                                                                                                                                                                                                                                                                                                                        
  Ras-related protein                          A0A024R7I3_HUMAN   RAB8A                                                                                          RAB8A, member RAS oncogene family, isoform CRA_a                               11                              4                                 1.08    1.75                   1.87*E* − 03            1.73           9.62*E* − 06
  A0A024RB87_HUMAN                             RAP1B              RAP1B, member of RAS oncogene family, isoform CRA_a                                            10                                                                             4                               1.66                              1.85    8.55*E* − 05           1.96                    7.63*E* − 11   
  RAB10_HUMAN                                  RAB10              Ras-related protein Rab-10                                                                     9                                                                              3                               0.71                              1.74    2.50*E* − 03           1.72                    2.60*E* − 05   
  RB11B_HUMAN                                  RAB11B             Ras-related protein Rab-11B                                                                    5                                                                              4                               0.73                              1.91    3.03*E* − 05           1.57                    1.03*E* − 05   
  RAB1B_HUMAN                                  RAB1B              Ras-related protein Rab-1B                                                                     12                                                                             6                               1.5                               1.73    2.07*E* − 03           1.73                    7.38*E* − 06   
  RB27B_HUMAN                                  RAB27B             Ras-related protein Rab-27B                                                                    5                                                                              4                               0.7                               1.70    1.33*E* − 03           1.59                    2.26*E* − 05   
  RAB7A_HUMAN                                  RAB7A              Ras-related protein Rab-7a                                                                     16                                                                             6                               1.94                              1.60    2.16*E* − 02           1.66                    1.48*E* − 04   
                                                                                                                                                                                                                                                                                                                                                                                        
  Serum amyloid                                D3DQX7_HUMAN       SAA1                                                                                           Serum amyloid A protein                                                        59                              5                                 9.88    0.53                   2.58*E* − 13            0.40           3.36*E* − 24
  SAA1_HUMAN                                   SAA1               Serum amyloid A-1 protein                                                                      40                                                                             4                               4.99                              0.48    1.21*E* − 15           0.38                    4.55*E* − 28   
  SAA2_HUMAN                                   SAA2               Serum amyloid A-2 protein                                                                      24                                                                             4                               4.99                              0.48    7.27*E* − 16           0.36                    3.08*E* − 31   
  SAMP_HUMAN                                   APCS               Serum amyloid P-component                                                                      228                                                                            8                               15.23                             0.83    8.13*E* − 03           0.70                    4.45*E* − 05   
                                                                                                                                                                                                                                                                                                                                                                                        
  von Willebrand factor                        L8E853_HUMAN       VWF                                                                                            von Willebrand factor                                                          189                             38                                0.98    1.68                   2.69*E* − 03            1.41           9.67*E* − 04
  VWF_HUMAN                                    VWF                von Willebrand factor                                                                          186                                                                            38                              0.93                              1.67    3.05*E* − 03           1.41                    7.94*E* − 04   

^a^Fold change provided by MASCOT.

^b^ *p* values calculated by edgeR to show the significance of different expression.

###### 

Up- and downregulated serum proteins specifically in LSSD-CHB.

  UniProt_ID         Gene_name        Description                                                                                                    Number of significant matches   Number of significant sequences   emPAI   FC^a^   *p*  value^b^
  ------------------ ---------------- -------------------------------------------------------------------------------------------------------------- ------------------------------- --------------------------------- ------- ------- ---------------
  *Upregulated*                                                                                                                                                                                                                         
  A0A024R6I9_HUMAN   SERPINA4         Serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 4, isoform CRA_a             79                              12                                3.79    1.78    5.24*E* − 05
  A0A075B6K3_HUMAN   IGLV2-11         Protein IGLV2-11 (fragment)                                                                                    8                               1                                 0.9     1.43    4.94*E* − 02
  A0A075B6K6_HUMAN   IGLV4-3          Protein IGLV4-3                                                                                                4                               1                                 0.51    1.54    1.23*E* − 02
  A0A075B6N7_HUMAN   IGHA2            Ig alpha-2 chain C region (fragment)                                                                           80                              6                                 1.94    1.44    4.71*E* − 02
  A0A0A0MS51_HUMAN   GSN              Gelsolin                                                                                                       146                             16                                2.42    1.51    2.86*E* − 02
  A0A0B4J1V4_HUMAN   IGHV1-46         Protein IGHV1-46 (fragment)                                                                                    2                               1                                 0.23    1.44    4.22*E* − 02
  A0N7J6_HUMAN                        REV25-2 (fragment)                                                                                             2                               2                                 0.47    1.92    3.69*E* − 03
  A0N8J1_HUMAN                        V(k)3 sequence of NG9 gene from fetal liver DNA (fragment)                                                     6                               1                                 1.1     1.49    1.49*E* − 02
  CPN2_HUMAN         CPN2             Carboxypeptidase N subunit 2                                                                                   94                              11                                2.09    1.48    1.88*E* − 02
  D3DNU8_HUMAN       KNG1             Kininogen 1, isoform CRA_a                                                                                     91                              14                                3.3     1.50    1.14*E* − 02
  FETUA_HUMAN        AHSG             Alpha-2-HS-glycoprotein                                                                                        57                              3                                 0.64    1.70    1.36*E* − 03
  FETUB_HUMAN        FETUB            Fetuin-B                                                                                                       9                               3                                 0.29    1.65    6.32*E* − 04
  HV208_HUMAN                         Ig heavy chain V-II region SESS                                                                                2                               1                                 0.21    2.27    1.25*E* − 08
  ITB1_HUMAN         ITGB1            Integrin beta-1                                                                                                3                               2                                 0.06    1.46    3.43*E* − 02
  KV119_HUMAN                         Ig kappa chain V-I region Wes                                                                                  21                              2                                 2.16    1.52    6.37*E* − 03
  KV308_HUMAN                         Ig kappa chain V-III region CLL                                                                                4                               1                                 0.49    1.65    8.16*E* − 03
  LV204_HUMAN                         Ig lambda chain V-II region TRO                                                                                7                               2                                 0.96    1.59    1.25*E* − 02
  PCYOX_HUMAN        PCYOX1           Prenylcysteine oxidase 1                                                                                       48                              9                                 1.89    1.43    3.70*E* − 02
  PEDF_HUMAN         SERPINF1         Pigment epithelium-derived factor                                                                              23                              9                                 1.54    1.48    1.56*E* − 02
  PON3_HUMAN         PON3             Serum paraoxonase/lactonase 3                                                                                  179                             12                                3.89    1.51    4.11*E* − 02
  Q6MZX9_HUMAN       DKFZp686M08189   Putative uncharacterized protein DKFZp686M08189                                                                124                             7                                 1.41    1.43    3.95*E* − 02
  Q6N091_HUMAN       DKFZp686C02220   Putative uncharacterized protein DKFZp686C02220 (fragment)                                                     71                              6                                 1.2     1.46    2.31*E* − 02
  Q6ZVX0_HUMAN                        cDNA FLJ41981 fis, clone SMINT2011888, highly similar to protein Tro alpha1 H,myeloma                          125                             7                                 1.38    1.43    4.13*E* − 02
  Q7Z379_HUMAN       DKFZp686K04218   Putative uncharacterized protein DKFZp686K04218 (fragment)                                                     124                             7                                 1.44    1.43    3.96*E* − 02
  Q8TE63_HUMAN                        Immunoglobulin light chain variable region (fragment)                                                          4                               2                                 0.97    1.45    4.51*E* − 02
  Q96K68_HUMAN                        cDNA FLJ14473 fis, clone MAMMA1001080, highly similar to *Homo sapiens* SNC73 protein (SNC73) mRNA             205                             9                                 1.77    1.45    2.93*E* − 02
  Q9NPP6_HUMAN                        Immunoglobulin heavy chain variant (fragment)                                                                  125                             7                                 1.75    1.43    4.92*E* − 02
  Q9UL83_HUMAN                        Myosin-reactive immunoglobulin light chain variable region (fragment)                                          14                              2                                 2.98    1.54    5.43*E* − 03
  Q9UL89_HUMAN                        Myosin-reactive immunoglobulin heavy chain variable region (fragment)                                          18                              5                                 8.63    1.49    2.16*E* − 02
  TRPM8_HUMAN        TRPM8            Transient receptor potential cation channel subfamily M member 8                                               3                               2                                 0.04    1.60    6.39*E* − 03
                                                                                                                                                                                                                                       
  *Downregulated*                                                                                                                                                                                                                       
  A0A024QZK7_HUMAN   HK1              Hexokinase                                                                                                     5                               1.00*E* + 00                      0.03    0.82    7.31*E* − 03
  A0A024R2X3_HUMAN   HYAL1            Hyaluronidase                                                                                                  12                              5.00*E* + 00                      0.55    0.73    2.82*E* − 05
  A0A024R451_HUMAN   SERPINE2         Serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 2, isoform CRA_a   17                              8                                 1.05    0.83    2.36*E* − 03
  A0A024RAG6_HUMAN   C1QA             Complement component 1, q subcomponent, A chain, isoform CRA_a                                                 12                              4                                 1.08    0.75    4.11*E* − 04
  A0A0S2Z3Y1_HUMAN   LGALS3BP         Lectin galactoside-binding soluble 3 binding protein isoform 1 (fragment)                                      247                             14                                4.17    0.71    2.49*E* − 06
  A0A0S2Z4D4_HUMAN   PLP1             Proteolipid protein 1 isoform 1 (fragment)                                                                     2                               1                                 0.11    0.40    1.65*E* − 04
  ADT4_HUMAN         SLC25A31         ADP/ATP translocase 4                                                                                          5                               1                                 0.16    0.65    1.28*E* − 02
  B1AHL2_HUMAN       FBLN1            Fibulin-1                                                                                                      74                              8                                 0.92    0.78    4.33*E* − 04
  CALU_HUMAN         CALU             Calumenin                                                                                                      12                              7                                 0.86    0.76    2.45*E* − 04
  CFAH_HUMAN         CFH              Complement factor H                                                                                            689                             31                                4.02    0.83    8.87*E* − 03
  LBP_HUMAN          LBP              Lipopolysaccharide-binding protein                                                                             148                             11                                3.18    0.79    3.74*E* − 04
  LRP1_HUMAN         LRP1             Prolow-density lipoprotein receptor-related protein 1                                                          37                              20                                0.16    0.83    7.44*E* − 03
  LTBP1_HUMAN        LTBP1            Latent-transforming growth factor beta-binding protein 1                                                       19                              8                                 0.16    0.77    8.36*E* − 04
  NUCB1_HUMAN        NUCB1            Nucleobindin-1                                                                                                 17                              7                                 0.66    0.78    5.80*E* − 04
  Q8NBH6_HUMAN                        Fibulin-1                                                                                                      125                             11                                2.25    0.75    1.26*E* − 04
  Q9HCC1_HUMAN                        Single chain Fv (fragment)                                                                                     10                              2                                 0.96    0.79    4.29*E* − 04
  THRB_HUMAN         F2               Prothrombin                                                                                                    1145                            18                                6.65    0.78    6.78*E* − 04

^a^Fold change provided by MASCOT.

^b^ *p* values calculated by edgeR to show the significance of different expression.

###### 

Up- and downregulated serum proteins exclusively in DHSM-CHB.

  UniProt_ID         Gene_name     Description                                                                                                                                               Number of significant matches   Number of significant sequences   emPAI   FC^a^   *p*  value^b^
  ------------------ ------------- --------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------- --------------------------------- ------- ------- ---------------
  *Upregulated*                                                                                                                                                                                                                                                                 
  A0A024R145_HUMAN   ALDOB         Fructose-bisphosphate aldolase                                                                                                                            5                               3                                 0.22    1.29    3.81*E* − 02
  A0A024R1N1_HUMAN   MYH9          Myosin, heavy polypeptide 9, nonmuscle, isoform CRA_a                                                                                                     17                              9                                 0.13    1.43    1.34*E* − 03
  A0A024R5H8_HUMAN   RAB6A         RAB6A, member RAS oncogene family, isoform CRA_b                                                                                                          8                               3                                 0.57    1.43    4.84*E* − 03
  A0A024R694_HUMAN   ACTN1         Actinin, alpha 1, isoform CRA_a                                                                                                                           20                              10                                0.42    1.33    1.97*E* − 02
  A0A024R6G3_HUMAN   FBLN5         Fibulin 5, isoform CRA_b                                                                                                                                  6                               3                                 0.27    1.33    6.31*E* − 03
  A0A024R9T1_HUMAN   hCG_39634     HCG39634, isoform CRA_a                                                                                                                                   2                               2                                 0.26    1.49    4.90*E* − 03
  A0A024RDB8_HUMAN   HPSE          Heparanase, isoform CRA_a                                                                                                                                 23                              6                                 0.55    1.36    1.03*E* − 03
  A0A024RDL8_HUMAN   ASL           Argininosuccinate lyase isoform 1                                                                                                                         10                              5                                 0.39    1.65    2.02*E* − 07
  A0A087WT59_HUMAN   TTR           Transthyretin                                                                                                                                             175                             7                                 5.66    1.34    3.42*E* − 02
  A0A087WUL0_HUMAN   TKFC          Triokinase/FMN cyclase                                                                                                                                    3                               3                                 0.15    1.28    9.35*E* − 03
  A0A0A0MSD0_HUMAN   SVEP1         Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1                                                                        4                               3                                 0.02    1.36    7.51*E* − 03
  A0A0A0MT32_HUMAN   LIPA          Lysosomal acid lipase/cholesteryl ester hydrolase                                                                                                         2                               1                                 0.09    1.38    4.78*E* − 03
  A0A0C4DFP6_HUMAN   CRTAC1        Cartilage acidic protein 1                                                                                                                                6                               5                                 0.24    1.23    3.57*E* − 02
  A0A0S2Z3F6_HUMAN   CETP          Cholesteryl ester transfer protein plasma isoform 1 (fragment)                                                                                            95                              14                                3.56    1.36    1.42*E* − 03
  A0A125QYY9_HUMAN                 IBM-B2 heavy chain variable region (fragment)                                                                                                             12                              2                                 0.83    1.42    2.25*E* − 03
  A0N7I9_HUMAN       F5-20         F5-20 (fragment)                                                                                                                                          4                               1                                 0.47    1.68    2.31*E* − 03
  A2NYU9_HUMAN                     Heavy chain Fab (fragment)                                                                                                                                2                               1                                 0.48    1.29    3.92*E* − 02
  A8K486_HUMAN                     Peptidyl-prolyl cis-trans isomerase                                                                                                                       2                               2                                 0.32    1.40    4.10*E* − 02
  ADIPO_HUMAN        ADIPOQ        Adiponectin                                                                                                                                               27                              5                                 2.13    1.32    1.12*E* − 02
  APOF_HUMAN         APOF          Apolipoprotein F                                                                                                                                          7                               3                                 0.5     1.29    1.84*E* − 02
  ASSY_HUMAN         ASS1          Argininosuccinate synthase                                                                                                                                4                               3                                 0.18    1.49    1.09*E* − 04
  ATPB_HUMAN         ATP5B         ATP synthase subunit beta, mitochondrial                                                                                                                  11                              2                                 0.22    1.34    3.74*E* − 02
  B3KTV0_HUMAN                     cDNA FLJ38781 fis, clone LIVER2000216, highly similar to HEAT SHOCK COGNATE 71 kDa PROTEIN                                                                5                               5                                 0.21    1.29    3.41*E* − 02
  B4DQK4_HUMAN                     cDNA FLJ53743, highly similar to tubulin alpha-3 chain                                                                                                    21                              6                                 0.81    1.61    1.06*E* − 03
  B4DVA7_HUMAN                     Beta-hexosaminidase                                                                                                                                       3                               2                                 0.15    1.26    1.84*E* − 02
  B7Z478_HUMAN       PSMB2         Proteasome (prosome, macropain) subunit, beta type, 2, isoform CRA_b                                                                                      2                               1                                 0.3     1.65    1.96*E* − 03
  BPIB1_HUMAN        BPIFB1        BPI fold-containing family B member 1                                                                                                                     11                              6                                 0.51    1.28    1.34*E* − 02
  BTD_HUMAN          BTD           Biotinidase                                                                                                                                               47                              6                                 1.12    1.54    1.69*E* − 06
  CAMP_HUMAN         CAMP          Cathelicidin antimicrobial peptide                                                                                                                        2                               1                                 0.29    1.43    2.64*E* − 03
  CAND1_HUMAN        CAND1         Cullin-associated NEDD8-dissociated protein 1                                                                                                             2                               1                                 0.02    1.36    2.60*E* − 03
  CATD_HUMAN         CTSD          Cathepsin D                                                                                                                                               2                               1                                 0.13    1.28    3.06*E* − 02
  DHSO_HUMAN         SORD          Sorbitol dehydrogenase                                                                                                                                    4                               3                                 0.32    1.67    2.46*E* − 07
  FIBA_HUMAN         FGA           Fibrinogen alpha chain                                                                                                                                    102                             22                                2.36    1.36    3.18*E* − 03
  G3P_HUMAN          GAPDH         Glyceraldehyde-3-phosphate dehydrogenase                                                                                                                  19                              7                                 1.37    1.37    5.07*E* − 03
  G3V5Z7_HUMAN       PSMA6         Proteasome subunit alpha type                                                                                                                             7                               4                                 0.58    1.44    9.01*E* − 04
  HV310_HUMAN                      Ig heavy chain V-III region HIL                                                                                                                           3                               1                                 0.5     1.48    1.12*E* − 03
  HV320_HUMAN                      Ig heavy chain V-III region GAL                                                                                                                           36                              3                                 1.91    1.32    2.19*E* − 02
  KV404_HUMAN                      Ig kappa chain V-IV region B17                                                                                                                            34                              2                                 1.45    1.45    4.98*E* − 04
  LDHB_HUMAN         LDHB          L-lactate dehydrogenase B chain                                                                                                                           4                               2                                 0.33    1.65    2.13*E* − 06
  M0QZB5_HUMAN       PPFIA4        Liprin-alpha-4 (fragment)                                                                                                                                 2                               1                                 0.03    1.33    2.70*E* − 02
  MARCO_HUMAN        MARCO         Macrophage receptor MARCO                                                                                                                                 2                               1                                 0.11    1.31    2.89*E* − 02
  MDR3_HUMAN         ABCB4         Phosphatidylcholine translocator ABCB4                                                                                                                    2                               1                                 0.04    1.32    1.23*E* − 02
  OTUB1_HUMAN        OTUB1         Ubiquitin thioesterase OTUB1                                                                                                                              2                               1                                 0.09    1.27    2.92*E* − 02
  PIGR_HUMAN         PIGR          Polymeric immunoglobulin receptor                                                                                                                         7                               4                                 0.18    1.34    4.27*E* − 03
  PSA3_HUMAN         PSMA3         Proteasome subunit alpha type-3                                                                                                                           8                               4                                 0.58    1.31    4.84*E* − 02
  PSB1_HUMAN         PSMB1         Proteasome subunit beta type-1                                                                                                                            4                               3                                 0.5     1.47    1.25*E* − 03
  Q6GMX4_HUMAN       IGL@          IGL@ protein                                                                                                                                              442                             6                                 7.15    1.27    3.98*E* − 02
  Q6PIQ7_HUMAN       IGL@          IGL@ protein                                                                                                                                              441                             6                                 6.39    1.27    4.86*E* − 02
  Q6ZNX5_HUMAN                     CDNA FLJ26936 fis, clone RCT06808                                                                                                                         5                               1                                 0.39    1.78    2.10*E* − 08
  Q9UL82_HUMAN                     Myosin-reactive immunoglobulin light chain variable region (fragment)                                                                                     46                              3                                 2.11    1.41    1.22*E* − 03
  QSOX1_HUMAN        QSOX1         Sulfhydryl oxidase 1                                                                                                                                      97                              20                                2.33    1.24    4.15*E* − 02
  TBA4A_HUMAN        TUBA4A        Tubulin alpha-4A chain                                                                                                                                    24                              8                                 0.86    1.55    1.38*E* − 03
  TBB1_HUMAN         TUBB1         Tubulin beta-1 chain                                                                                                                                      6                               4                                 0.33    1.30    2.87*E* − 02
  TBB8_HUMAN         TUBB8         Tubulin beta-8 chain                                                                                                                                      7                               5                                 0.42    1.32    3.10*E* − 02
  TRML1_HUMAN        TREML1        Trem-like transcript 1 protein                                                                                                                            3                               1                                 0.09    1.42    1.05*E* − 03
  TSP1_HUMAN         THBS1         Thrombospondin-1                                                                                                                                          365                             34                                4.23    1.37    1.66*E* − 03
  TYPH_HUMAN         TYMP          Thymidine phosphorylase                                                                                                                                   3                               3                                 0.19    1.23    4.67*E* − 02
                                                                                                                                                                                                                                                                               
  *Downregulated*                                                                                                                                                                                                                                                               
  A0A024CIM4_HUMAN                 Carboxylic ester hydrolase                                                                                                                                7                               3                                 0.17    0.81    1.43*E* − 02
  A0A024R6I6_HUMAN   SERPINA10     Serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 10, isoform CRA_b                                                       65                              12                                2.73    0.75    1.46*E* − 04
  A0A024R6K8_HUMAN   WARS          Tryptophanyl-tRNA synthetase, isoform CRA_a                                                                                                               5                               2                                 0.1     0.82    4.87*E* − 02
  A0A024R853_HUMAN   IQCE          IQ motif containing E, isoform CRA_b                                                                                                                      2                               1                                 0.04    0.74    1.67*E* − 03
  A0A024R9J3_HUMAN   COLEC10       Collectin subfamily member 10 (C-type lectin), isoform CRA_a                                                                                              4                               2                                 0.28    0.83    2.40*E* − 02
  A0A075B6S2_HUMAN   IGKV2D-29     Protein IGKV2D-29 (fragment)                                                                                                                              26                              3                                 2.47    0.77    2.05*E* − 03
  A0A087X054_HUMAN   HYOU1         Hypoxia upregulated protein 1                                                                                                                             4                               2                                 0.08    0.58    2.93*E* − 08
  A0A0A7C3P2_HUMAN   HLA-A         MHC class I antigen (fragment)                                                                                                                            8                               3                                 0.72    0.77    1.24*E* − 03
  A0A0J9YX35_HUMAN                 Uncharacterized protein (fragment)                                                                                                                        2                               1                                 0.51    0.74    3.43*E* − 03
  A0A0X9TD47_HUMAN                 MS-D1 light chain variable region (fragment)                                                                                                              30                              3                                 5.49    0.83    1.31*E* − 02
  A2AP_HUMAN         SERPINF2      Alpha-2-antiplasmin                                                                                                                                       67                              10                                1.86    0.74    2.85*E* − 04
  A2J1N4_HUMAN                     Rheumatoid factor RF-IP24 (fragment)                                                                                                                      10                              2                                 1.08    0.80    4.59*E* − 03
  A2J1N5_HUMAN                     Rheumatoid factor RF-ET6 (fragment)                                                                                                                       15                              1                                 1.65    0.79    6.40*E* − 04
  A2MYD0_HUMAN       V1-17         V1-17 protein (fragment)                                                                                                                                  8                               3                                 1.87    0.83    1.21*E* − 02
  A2NB45_HUMAN                     Cold agglutinin FS-1 L-chain (fragment)                                                                                                                   23                              2                                 1.39    0.69    3.83*E* − 04
  A3RKG7_HUMAN                     Coagulation factor VII (fragment)                                                                                                                         17                              6                                 2.02    0.77    7.55*E* − 04
  ALBU_HUMAN         ALB           Serum albumin                                                                                                                                             1841                            31                                17.82   0.67    1.64*E* − 06
  AMBP_HUMAN         AMBP          Protein AMBP                                                                                                                                              34                              3                                 0.75    0.76    4.96*E* − 04
  ATS13_HUMAN        ADAMTS13      A disintegrin and metalloproteinase with thrombospondin motifs 13                                                                                         22                              8                                 0.26    0.81    6.52*E* − 03
  B2RBZ5_HUMAN                     cDNA, FLJ95778, highly similar to *Homo sapiens* serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 10 (SERPINA10), mRNA   58                              11                                2.2     0.76    1.77*E* − 04
  B4DL32_HUMAN                     cDNA FLJ59922, highly similar to keratin, type II cytoskeletal 5                                                                                          7                               2                                 0.33    0.83    2.87*E* − 02
  B4DN21_HUMAN                     cDNA FLJ53365, highly similar to *Homo sapiens* fibronectin 1 (FN1), transcript variant 4, mRNA                                                           384                             8                                 6.85    0.77    1.76*E* − 03
  B4E1B2_HUMAN                     cDNA FLJ53691, highly similar to serotransferrin                                                                                                          142                             16                                2.78    0.59    6.58*E* − 09
  B7Z8B6_HUMAN                     cDNA FLJ54395, highly similar to inter-alpha-trypsin inhibitor heavy chain H1                                                                             68                              8                                 1.2     0.71    6.32*E* − 06
  BIG3_HUMAN         ARFGEF3       Brefeldin A-inhibited guanine nucleotide-exchange protein 3                                                                                               3                               1                                 0.01    0.71    7.55*E* − 03
  BLVRB_HUMAN        BLVRB         Flavin reductase (NADPH)                                                                                                                                  6                               2                                 0.28    0.81    1.46*E* − 02
  CATA_HUMAN         CAT           Catalase                                                                                                                                                  3                               3                                 0.15    0.80    4.91*E* − 03
  CATF_HUMAN         CTSF          Cathepsin F                                                                                                                                               6                               4                                 0.23    0.81    2.58*E* − 03
  CO2_HUMAN          C2            Complement C2                                                                                                                                             20                              9                                 0.5     0.78    1.25*E* − 03
  CO5_HUMAN          C5            Complement C5                                                                                                                                             416                             52                                4.64    0.74    4.50*E* − 04
  F13B_HUMAN         F13B          Coagulation factor XIII B chain                                                                                                                           4                               3                                 0.15    0.76    1.83*E* − 03
  GLUC_HUMAN         GCG           Glucagon                                                                                                                                                  2                               1                                 0.3     0.81    8.52*E* − 03
  H0YLF3_HUMAN       B2M           Beta-2-microglobulin (fragment)                                                                                                                           4                               1                                 0.75    0.77    5.98*E* − 03
  HEMO_HUMAN         HPX           Hemopexin                                                                                                                                                 63                              9                                 1.51    0.65    4.59*E* − 08
  HGFA_HUMAN         HGFAC         Hepatocyte growth factor activator                                                                                                                        15                              4                                 0.39    0.82    4.99*E* − 03
  HV306_HUMAN                      Ig heavy chain V-III region BUT                                                                                                                           36                              5                                 6.45    0.76    2.60*E* − 04
  HV314_HUMAN                      Ig heavy chain V-III region LAY                                                                                                                           3                               2                                 0.88    0.81    8.62*E* − 03
  HV317_HUMAN                      Ig heavy chain V-III region ZAP                                                                                                                           3                               1                                 0.56    0.78    1.26*E* − 03
  IC1_HUMAN          SERPING1      Plasma protease C1 inhibitor                                                                                                                              34                              7                                 0.82    0.62    1.32*E* − 09
  INHBC_HUMAN        INHBC         Inhibin beta C chain                                                                                                                                      16                              3                                 0.36    0.82    1.47*E* − 02
  ITIH1_HUMAN        ITIH1         Inter-alpha-trypsin inhibitor heavy chain H1                                                                                                              252                             22                                3       0.81    1.20*E* − 02
  K1C10_HUMAN        KRT10         Keratin, type I cytoskeletal 10                                                                                                                           32                              8                                 0.87    0.70    1.75*E* − 06
  K1C14_HUMAN        KRT14         Keratin, type I cytoskeletal 14                                                                                                                           3                               2                                 0.11    0.68    1.74*E* − 06
  K1C9_HUMAN         KRT9          Keratin, type I cytoskeletal 9                                                                                                                            24                              8                                 0.65    0.81    5.29*E* − 03
  K22E_HUMAN         KRT2          Keratin, type II cytoskeletal 2 epidermal                                                                                                                 38                              14                                1.31    0.77    4.04*E* − 04
  K2C1_HUMAN         KRT1          Keratin, type II cytoskeletal 1                                                                                                                           104                             19                                4.31    0.66    1.81*E* − 08
  K2C6B_HUMAN        KRT6B         Keratin, type II cytoskeletal 6B                                                                                                                          18                              4                                 0.51    0.63    3.76*E* − 09
  K7ER74_HUMAN       APOC4-APOC2   Protein APOC4-APOC2                                                                                                                                       111                             5                                 7.56    0.68    7.94*E* − 05
  KV201_HUMAN                      Ig kappa chain V-II region Cum                                                                                                                            23                              2                                 1.98    0.54    2.24*E* − 09
  L0R8K6_HUMAN       TRIM25        Alternative protein TRIM25                                                                                                                                13                              1                                 0.9     0.77    8.84*E* − 04
  MASP1_HUMAN        MASP1         Mannan-binding lectin serine protease 1                                                                                                                   36                              7                                 0.63    0.83    1.78*E* − 02
  PCDGG_HUMAN        PCDHGB4       Protocadherin gamma-B4                                                                                                                                    3                               1                                 0.03    0.80    4.10*E* − 02
  PLA1A_HUMAN        PLA1A         Phospholipase A1 member A                                                                                                                                 2                               1                                 0.07    0.83    5.39*E* − 03
  PROC_HUMAN         PROC          Vitamin K-dependent protein C                                                                                                                             84                              9                                 1.71    0.78    1.40*E* − 03
  Q06AH7_HUMAN       TF            Transferrin                                                                                                                                               141                             16                                2.64    0.59    6.40*E* − 09
  Q1T720_HUMAN       HLA-B         MHC class I antigen (fragment)                                                                                                                            9                               6                                 0.9     0.77    1.30*E* − 03
  Q6U2L6_HUMAN       C4B           C4B (fragment)                                                                                                                                            79                              6                                 27.02   0.69    2.60*E* − 05
  Q9P1C5_HUMAN                     PRO2769                                                                                                                                                   43                              7                                 0.97    0.70    1.53*E* − 06
  Q9UMV1_HUMAN       C4B           Complement C4B1a (fragment)                                                                                                                               8                               1                                 1.56    0.77    3.10*E* − 04
  Q9UNU2_HUMAN       C4B           Complement protein C4B frameshift mutant (fragment)                                                                                                       524                             14                                26.83   0.64    8.08*E* − 07
  QPCT_HUMAN         QPCT          Glutaminyl-peptide cyclotransferase                                                                                                                       7                               4                                 0.43    0.83    1.22*E* − 02
  TIMP3_HUMAN        TIMP3         Metalloproteinase inhibitor 3                                                                                                                             2                               1                                 0.11    0.75    1.01*E* − 03

^a^Fold change provided by MASCOT.

^b^ *p* values calculated by edgeR to show the significance of different expression.

[^1]: Academic Editor: Yasunobu Matsuda
